Dysphagia, Esophageal
13
5
5
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 13 trials
100.0%
+13.5% vs benchmark
8%
1 trials in Phase 3/4
0%
0 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (13)
Striated Esophageal Motor Function Modulation in Health and Disease
Exercise Training for Cervicogenic Dysphagia
Per-oral Endoscopic Myotomy (POEM) in Patients with Postfundplication Dysphagia
ThickenUp® Gel Express for Patients with Dysphagia
Esophageal Impedance and Manometry Measurements and Dysphagia Symptom Scoring
Buspirone for Weak or Absent Esophageal Peristalsis
Effect of Botulinum Toxin Injection Into Upper Esophageal Sphincter in Patients With Medullary Infarction
A Phase II Clinical Study of Epigallocatechin-3-gallate in Patients With Esophageal Squamous Cancer
Migration Rates of Sutured vs Non-sutured Esophageal Stent Placement
Long-term Follow-up After Hiatal Hernia Repair by Tension-free Mesh Closure or Simple Suturing
Dose-response Effect of the Thickener Tsururinko Quickly
Validation of Instruments Used for Assessment of Dysphagia in Patients With Esophageal Cancer
Post-thyroidectomy Dysphagia: An International Multicentric CONSORT - Compatible RCT